Partnership focused on utilizing Axiomer™ to develop editing oligonucleotides targeting an underlying genetic variant that causes Rett syndromeCollaboration expands ProQR’s commitment to advance the development of therapies for central nervous system diseases
… of disease areas for the in-house R&D pipeline and partnerships Is responsible for providing an early and … and expression, sexual orientation, marriage, or civil partnership status. At ProQR we want to create an inclusive …